Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece

BACKGROUND: Patients having chronic schizophrenia with frequent relapses and hospitalizations represent a great challenge, both clinically and financially. Risperidone long-acting injection (RIS-LAI) has been the main LAI atypical antipsychotic treatment in Greece. Paliperidone palmitate (PP-LAI) ha...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Einarson, Thomas R, Geitona, Maria, Chaidemenos, Alexandros, Karpouza, Vasiliki, Mougiakos, Theodoros, Paterakis, Periklis, Ploumpidis, Dimitrios, Potamitis-Komis, Dionyssios, Zilbershtein, Roman, Vicente, Colin, Piwko, Charles, Kakkavas, Panagiotis, Paparouni, Konstantina, Jensen, Rasmus C D, Hemels, Michiel E H
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2012
נושאים:
Primary Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3430591/
https://ncbi.nlm.nih.gov/pubmed/22747533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1744-859X-11-18
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים